» Articles » PMID: 17488276

Inhibition of Mitochondrial Function in Astrocytes: Implications for Neuroprotection

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2007 May 10
PMID 17488276
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Much evidence suggests that astrocytes protect neurons against ischemic injury. Although astrocytes are more resistant to some insults than neurons, few studies offer insight into the real time changes of astrocytic protective functions with stress. Mitochondria are one of the primary targets of ischemic injury in astrocytes. We investigated the time course of changes in astrocytic ATP levels, plasma membrane potential, and glutamate uptake, a key protective function, induced by mitochondrial inhibition. Our results show that significant functional change precedes reduction in astrocytic viability with mitochondrial inhibition. Using the mitochondrial inhibitor fluorocitrate (FC, 0.25 mmol/L) that is preferentially taken by astrocytes we found that inhibition of astrocyte mitochondria increased vulnerability of co-cultured neurons to glutamate toxicity. In our studies, the rates of FC-induced astrocytic mitochondrial depolarization were accelerated in mixed astrocyte/neuron cultures. We hypothesized that the more rapid mitochondrial depolarization was promoted by an additional energetic demand imposed be the co-cultured neurons. To test this hypothesis, we exposed pure astrocytic cultures to 0.01-1 mmol/L aspartate as a metabolic load. Aspartate application accelerated the rates of FC-induced mitochondrial depolarization, and, at 1 mmol/L, induced astrocytic death, suggesting that strong energetic demands during ischemia can compromise astrocytic function and viability.

Citing Articles

The Glutamate/GABA-Glutamine Cycle: Insights, Updates, and Advances.

Andersen J J Neurochem. 2025; 169(3):e70029.

PMID: 40066661 PMC: 11894596. DOI: 10.1111/jnc.70029.


The Dose-Dependent Effects of Fluorocitrate on the Metabolism and Activity of Astrocytes and Neurons.

Zhuang H, Yuan D, Shi F, Wu X, Luo Z, Gan W Brain Sci. 2025; 15(2).

PMID: 40002432 PMC: 11853058. DOI: 10.3390/brainsci15020099.


Vitamin D injection into the dorsal-CA1 hippocampus improves short-term sleep deprivation induced cognitive impairment in male rats.

Rezagholizadeh A, Firoozi A, Tavassoli Z, Shojaei A, Hosseinmardi N, Mirnajafi-Zadeh J Heliyon. 2025; 10(15):e34853.

PMID: 39959779 PMC: 11829095. DOI: 10.1016/j.heliyon.2024.e34853.


Novel hypothesis and therapeutic interventions for irritable bowel syndrome: interplay between metal dyshomeostasis, gastrointestinal dysfunction, and neuropsychiatric symptoms.

Nakagawa Y, Yamada S Mol Cell Biochem. 2024; .

PMID: 39503802 DOI: 10.1007/s11010-024-05153-3.


Metabolomics-Based Study of the Protective Effect of 4-Hydroxybenzyl Alcohol on Ischemic Astrocytes.

Xiao T, Yu X, Tao J, Yang L, Duan X Int J Mol Sci. 2024; 25(18).

PMID: 39337395 PMC: 11432256. DOI: 10.3390/ijms25189907.


References
1.
Swanson R, Ying W, Kauppinen T . Astrocyte influences on ischemic neuronal death. Curr Mol Med. 2004; 4(2):193-205. DOI: 10.2174/1566524043479185. View

2.
Bambrick L, Kristian T, Fiskum G . Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res. 2004; 29(3):601-8. DOI: 10.1023/b:nere.0000014830.06376.e6. View

3.
Rehncrona S, Mela L, Siesjo B . Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke. 1979; 10(4):437-46. DOI: 10.1161/01.str.10.4.437. View

4.
Akerman K, Jarvisalo J . Effects of ionophores and metabolic inhibitors on the mitochondrial membrane potential within isolated hepatocytes as measured with the safranine method. Biochem J. 1980; 192(1):183-90. PMC: 1162321. DOI: 10.1042/bj1920183. View

5.
Drejer J, Larsson O, Schousboe A . Characterization of uptake and release processes for D- and L-aspartate in primary cultures of astrocytes and cerebellar granule cells. Neurochem Res. 1983; 8(2):231-43. DOI: 10.1007/BF00963923. View